•
The molecules could have applications in targeted drug delivery processes, according to research lead Prof Thorfinnur Gunnlaugsson. Read more: Trinity scientists develop ‘Malteser’ molecules in biotech breakthrough
•
Marie Unger discusses the need for modern-day companies to bring their review processes into the 21st century. Read more: Is it time to put the annual review under the microscope?
•
In today’s digital-first world, the software your business relies on isn’t just a tool; it’s the backbone of your operations, often driving everything from sales and HR to finance. Consequently, […] The post Guest post: Software licensing: Reducing risks, cutting costs and securing success appeared first on Legal IT Insider.
•
The plans have drawn criticism from tech giant Nvidia, as well as from the Information Technology Industry Council. Read more: US announces new export rule to curb misuse of AI chips
•
Gatekeeping at work has the potential to negatively impact an organisation, on an individual and collective level. Read more: How to slam the door on workplace gatekeeping
•
Aquila Bioscience’s approach is informed by an extensive review of microbiome research originating from the International Space Station. Read more: Galway’s Aquila Biosciences and ESA partner for safer space exploration
•
The team are currently reviewing opportunities for another launch attempt. Read more: Technical issues delay Blue Origin rocket launch
•
The Commission has found that the merger can proceed if proposed requirements are met. Read more: EU approves Synopsys’ acquisition of Ansys, subject to conditions
•
The news comes as Vantage Data Centres, Nscale and Kyndryl have committed to investing £14bn into the UK to build AI infrastructure and create more than 13,000 jobs. Read more: OpenAI rival planned by UK government in new AI strategy
•
The fresh funding will be used to advance its AI offering and support its ongoing acquisition plans. Read more: Irish-founded Overhaul secures $55m